Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
| covid-19:treatments:sotrovimab [2022/01/14 00:11] brian | covid-19:treatments:sotrovimab [2023/03/18 23:36] (current) liam | ||
|---|---|---|---|
| Line 8: | Line 8: | ||
| Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the investigational monoclonal antibody therapeutic was granted on May 26, 2021 | Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the investigational monoclonal antibody therapeutic was granted on May 26, 2021 | ||
| + | |||
| + | ==Clinical Trials== | ||
| + | COMET-ICE Phase 3 RCT: 1,057 adult participants were randomized to sotrovimab or placebo. The trial demonstrated a 79% reduction in hospitalization (6/528 vs placebo 30/529) for those that received the treatment.(([[https:// | ||
| + | |||
| + | |||
| + | ==Sales== | ||
| + | 11 January 2022 U.S.A. purchased 600,000 doses((https:// | ||
| + | 17 November 2021 U.S.A. purchases $1 billion worth of the mab((https:// | ||
| + | |||
| + | ===== External links ===== | ||
| + | |||
| + | * [[https:// | ||